Management of Chronic Conditions

The following list presents children's health care quality measures from the AHRQ-CMS Pediatric Quality Measures Program (PQMP). These measures have been developed by the PQMP Centers of Excellence (COEs). The list includes links to brief measure fact sheets and full reports, as well as technical specifications and other supporting documents as they become available.

Measure Developer: Mount Sinai Collaboration for Advancing Pediatric Quality Measures (CAPQuaM)

Mental Health Follow-up

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents*
Mental Health Follow-up Measures I: Timeliness of Follow-up Visits Following Hospital Discharge of Children with a Primary Mental Health Diagnosis Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.

Emergency Room Use by Children with Asthma

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents*
CAPQuaM PQMP Asthma I: Rate of Emergency Department Visit Use for Children Managed for Persistent Asthma Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
CAPQuaM PQMP Asthma II: Distribution of Emergency Department Visit Use for Children Managed for Persistent Asthma Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
CAPQuaM PQMP Asthma III: Primary Care Connection Prior to Emergency Department Visits for Children with Identifiable Asthma Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
CAPQuaM PQMP Asthma IV: Primary Care Connection After Emergency Department Visits for Asthma Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
CAPQuaM PQMP Asthma V: Appropriateness of Emergency Department Visits for Children and Adolescents with Identifiable Asthma Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.

*Persons using assistive technology may not be able to fully access information in these files. For assistance, please contact Lawrence Kleinman, Collaboration for Advancing Pediatric Quality Measures, at lxk232@case.edu.

Measure Developer: Center of Excellence on Quality of Care Measures for Children with Complex Needs (COE4CCN)

Pediatric Algorithm

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents
Continuity of Primary Care for Children with Medical Complexity Full Report (PDF, 99 KB) Section 1, Table 1, Definitions of Three Levels of Medical Complexity (PDF, 125 KB)
Section 2, Technical Specifications (PDF, 38 KB)
Section 6, Tables 2 and 3 (PDF, 156 KB)
Section 12, Tables 4 and 5 (PDF, 125 KB)
Written Statement (PDF, 133 KB)

Care Coordination

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents
Family Experiences with Coordination of Care (FECC) Measurement Set
Select here to view CHIPRA Webinar.
Fact Sheet (PDF, 684 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.

Persons using assistive technology may not be able to fully access information in these files. For assistance, please contact Rita Mangione-Smith, Center of Excellence on Quality of Care Measures for Children with Complex Needs, at rita.mangionesmith@seattlechildrens.org.

Measure Developer: Center of Excellence for Pediatric Quality Measurement (CEPQM)

Pediatric Algorithm

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents**
Children with Disabilities Algorithm Full Report (PDF, 227 KB) Section 2, Technical Specification (PDF, 618 KB)
Section 6, Figure 6-A (PDF, 102 KB)
Section 6, Figures 6-B.1 and 6-B.2 (PDF, 148 KB)
Section 7, Table 7-A (PDF, 87 KB)
Section 7, Table 7-B (PDF, 87 KB)
Section 7, Table 7-D (PDF, 88 KB)
Written Statement (PDF, 107 KB)

**Persons using assistive technology may not be able to fully access information in these files. For assistance, please contact the Pediatric Quality Measures Program at PQMP@ahrq.hhs.gov.

Measure Developer: Pediatric Measurement Center of Excellence (PMCoE)

Attention Deficit/Hyperactivity Disorder (ADHD) Care

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents
ADHD Follow-up Care Fact Sheet (PDF, 259 KB)
Full Report (PDF, 205 KB)
Attachment 2.1 (PDF, 247 KB)
Attachment 3.1 (PDF, 112 KB)
Attachments 5.1–5.5 (PDF, 3.7 MB)
Attachment 6.1 (PDF, 2.1 MB)
Attachment 6.2 (PDF, 2.1 MB)
Attachment 7.1–7.6 (PDF, 1.1 MB)
Attachment 9.1 (PDF, 263 KB)
Attachment 13.1 (PDF, 668 KB)
Materials Written Statement (PDF, 640 KB)
Accurate ADHD Diagnosis Fact Sheet (PDF, 634 KB)
Full Report (PDF, 418 KB)
Measure 1, Section 2, Attachment 1 (PDF, 309 KB)
Measure 1, Section 2, Attachment 2 (PDF, 38 KB)
Measure 1, Section 2, Attachment 3 (PDF, 85 KB)
Measure 1, Section 2, Attachment 4 (Excel, 77 KB)
Measure 1, Section 2, Attachment 5 (PDF, 291 KB)
Measure 1, Section 2, Attachment 6 (PDF, 117 KB)
Measure 1, Section 5, Attachment 2 (PDF, 59 KB)
Measure 1, Section 5, Attachment 3 (PDF, 43 KB)
Measure 1, Section 5, Attachment 4 (PDF, 53 KB)
Measure 1, Section 5, Attachment 5 (PDF, 790 KB)
Measure 1, Section 6, Attachment 1 (Excel, 34 KB)
Measure 1, Section 6, Attachment 2 (PDF, 28 KB)
Measure 1, Section 8, Attachment 1 (PDF, 85 KB)
Measure 1, Section 8, Attachment 2 (PDF, 48 KB)
Measure 1, Section 14, Attachment 1 (PDF, 325 KB)
References (PDF, 36 KB)
Materials Written Statement (PDF, 109 KB)
Behavior Therapy as First-Line Treatment for Preschool-Aged Children with ADHD Fact Sheet (PDF, 337 KB)
Full Report (PDF, 151 KB)
Section 2, Attachment 1 (PDF, 306 KB)
Section 2, Attachment 2 (PDF, 43 KB)
Section 2, Attachment 3 (PDF, 80 KB)
Section 2, Attachment 4 (PDF, 291 KB)
Section 5, Attachment 1 (PDF, 229 KB)
Section 5, Attachment 2 (PDF, 74 KB)
Section 5, Attachment 3 (PDF, 38 KB)
Section 5, Attachment 4 (PDF, 51 KB)
Section 5, Attachment 5 (PDF, 730 KB)
Section 6, Attachment 1 (Excel, 39 KB)
Section 6, Attachment 2 (PDF, 28 KB)
Section 8, Attachment 1 (PDF, 86 KB)
Section 14, Attachment 1 (PDF, 296 KB)
References (PDF, 53 KB)
Materials Written Statement (PDF, 99 KB)

Persons using assistive technology may not be able to fully access information in these files. For assistance, please contact Ramesh Sachdeva, Pediatric Measurement Center of Excellence, at SachdevR@upstate.edu.

Measure Developer: National Collaborative for Innovation in Quality Measurement (NCINQ)

Use of Antipsychotics

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents§
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.
Follow-up Visit for Children and Adolescents on Antipsychotics Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.
Metabolic Screening for Children and Adolescents Newly on Antipsychotics Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.
Metabolic Monitoring for Children and Adolescents on Antipsychotics Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.
Use of Multiple Concurrent Antipsychotics in Children and Adolescents Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.
Safe and Judicious Antipsychotic Use in Children and Adolescents Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.
Use of Antipsychotic Medications in Very Young Children Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents Fact Sheet (PDF, 315 KB)
Full Report (In preparation for posting—available upon request)
In preparation for posting—available upon request.

§Persons using assistive technology may not be able to fully access information in these files. For assistance, please contact Sarah Hudson Scholle, National Collaborative for Innovation in Quality Measurement, at Scholle@ncqa.org.

Measure Developer: Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium (Q-METRIC)

Sickle Cell Treatment

Subcategory/Measure Products Measure Technical Specifications and Other Supporting Documents
Appropriate Outpatient Blood Testing
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Anticipatory Guidance for Pain Management
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Anticipatory Guidance for Prevention of Severe Fever and Infection
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Anticipatory Guidance for the Prevention of Stroke
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Anticipatory Guidance Regarding School Attendance
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Anticipatory Guidance for Prevention of Splenic Complications
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Anticipatory Guidance Regarding Hydroxyurea Treatment
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
HgB S Monitoring at Time of Transfusion (Chronic Transfusion)
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Appropriate Emergency Department (ED) Blood Testing
Accepted by NQMC.
Full Report (PDF, 175 KB) Section 2, Technical Specifications (PDF, 74 KB)
Appropriate Blood Testing in the ED for Children with SCD, Tables 1-7 (PDF, 68 KB)
Appropriate ED Fever Management
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Appropriate ED Pain Assessment
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Appropriate ED Pain Management
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Satisfaction with Hematologist Care
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Satisfaction with ED Care
Accepted by NQMC.
Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Timeliness of Confirmatory Testing for Sickle Cell Disease (SCD)
Accepted by NQMC
Fact Sheet (PDF, 323 KB)
Full Report (PDF, 136 KB)
Section 1. Basic Measurement Information (PDF, 65 KB)
Section 2. SCD Measure 1: Specifications (PDF, 134 KB)
Section 5. Table 3 (PDF, 87 KB)
Section 7. Table 4 (PDF, 59 KB)
Section 7. Table 5 (PDF, 39 KB)
Section 7. Table 6 (PDF, 41 KB)
Section 8. Tables 7, 8, and 9 (PDF, 101 KB)
Written Statement (PDF, 62 KB)
Appropriate Antibiotic Prophylaxis for Children with Sickle Cell Disease Full Report (In preparation for posting—available upon request) In preparation for posting—available upon request.
Timeliness of Antibiotic (Penicillin) Prophylaxis for Children with SCD
Accepted by NQMC.
Fact Sheet (PDF, 323 KB)
Full Report (PDF, 132 KB)
Graphics for Section 1 (PDF, 130 KB)
Technical Specifications (PDF, 168 KB)
Graphics for Section 5 (PDF, 131 KB)
Graphics for Section 6-A, Reliability (PDF, 112 KB)
Graphics for Section 6-B, Validity (PDF, 109 KB)
Graphics for Section 7-A, Race/Ethnicity (PDF, 116 KB)
Graphics for Section 7-C, Disparities (PDF, 96 KB)
Graphics for Section 7-D, Rurality/Urbanicity (PDF, 97 KB) 
Graphics for Section 8, Feasibility (PDF, 126 KB) 
Written Statement (PDF, 60 KB)
Transcranial Doppler Ultrasonography Screening Among Children with Sickle Cell Anemia
Accepted by NQMC.
Fact Sheet (PDF, 335 KB)
Full Report (PDF, 206 KB)
Section 2, Technical Specifications (PDF, 455 KB)
Written Statement (PDF, 60 KB)

⁑Persons using assistive technology may not be able to fully access information in these files. For assistance, please contact the Pediatric Quality Measures Program at PQMP@ahrq.hhs.gov.

Page last reviewed October 2017
Page originally created April 2017
Internet Citation: Management of Chronic Conditions. Content last reviewed October 2017. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/pqmp/measures/management-of-chronic-conditions.html